130 related articles for article (PubMed ID: 23136626)
1. Influence of nonregional lymph node metastasis as a prognostic factor in metastatic prostate cancer patients.
Cho S; Kang SG; Tae BS; Cheon J
Korean J Urol; 2012 Oct; 53(10):673-9. PubMed ID: 23136626
[TBL] [Abstract][Full Text] [Related]
2. Surgery on Metastatic Foci is a Better Strategy for Stage IV Breast Cancer Patients with only Nonregional Lymph Node Metastasis.
Jiao Y; Guo X; Wu H; Lv Q
Adv Ther; 2023 Jul; 40(7):3247-3262. PubMed ID: 37270436
[TBL] [Abstract][Full Text] [Related]
3. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Ali A; Hoyle A; Mistry H; Clarke NW
BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer.
Heesterman BL; van der Poel HG; Schoots IG; Mehra N; Aben KKH
BJU Int; 2022 Aug; 130(2):217-225. PubMed ID: 34741789
[TBL] [Abstract][Full Text] [Related]
5. Regional location of lymph node metastases predicts survival in patients with
Wang ZP; Chen JR; Zhao JG; Zhu S; Zhang XM; Liang JY; He B; Ni YC; Sun GX; Shen PF; Zeng H
Asian J Androl; 2023; 25(4):462-467. PubMed ID: 36348577
[TBL] [Abstract][Full Text] [Related]
6. Impact of non-regional lymph node metastases accurately revealed on
Jiang Z; Fan J; Gan C; Dong X; Gao G; Wang Z; He D; Li L; Duan X; Wu K
EJNMMI Res; 2023 Jul; 13(1):64. PubMed ID: 37410264
[TBL] [Abstract][Full Text] [Related]
7. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ
Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853
[TBL] [Abstract][Full Text] [Related]
8. Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis.
Jiao Y; Guo X; Lv Q
Breast Cancer; 2023 Jul; 30(4):647-656. PubMed ID: 37103742
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with prostate carcinoma presenting as nonregional lymph node metastases.
Furuya Y; Akakura K; Akimoto S; Ito H
Urol Int; 1998 Oct; 61(1):17-21. PubMed ID: 9792977
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis.
Guo Y; Mao S; Zhang A; Wang R; Zhang Z; Zhang J; Wang L; Zhang W; Wu Y; Ye L; Yang B; Yao X
J Cancer; 2019; 10(3):556-567. PubMed ID: 30719152
[No Abstract] [Full Text] [Related]
11. Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer.
Koo KC; Park SU; Kim KH; Rha KH; Hong SJ; Yang SC; Chung BH
Yonsei Med J; 2015 Sep; 56(5):1206-12. PubMed ID: 26256961
[TBL] [Abstract][Full Text] [Related]
12. Risk of prostate carcinoma death in patients with lymph node metastasis.
Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
[TBL] [Abstract][Full Text] [Related]
13. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
[TBL] [Abstract][Full Text] [Related]
14. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer.
Yoshida S; Takahara T; Ishii C; Arita Y; Waseda Y; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Fujii Y
Clin Genitourin Cancer; 2020 Aug; 18(4):e391-e396. PubMed ID: 31902713
[TBL] [Abstract][Full Text] [Related]
15. The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer.
Pond GR; Sonpavde G; de Wit R; Eisenberger MA; Tannock IF; Armstrong AJ
Eur Urol; 2014 Jan; 65(1):3-6. PubMed ID: 24120464
[TBL] [Abstract][Full Text] [Related]
16. Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer.
Whitney CA; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Cancer; 2016 Dec; 122(24):3848-3855. PubMed ID: 27505036
[TBL] [Abstract][Full Text] [Related]
17. Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
Kodama H; Koie T; Oikawa M; Narita T; Tanaka T; Noro D; Iwamura H; Tobisawa Y; Yoneyama T; Hashimoto Y; Ohyama C
Int Urol Nephrol; 2020 Apr; 52(4):671-679. PubMed ID: 31897875
[TBL] [Abstract][Full Text] [Related]
18. Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.
Tsai HL; Chen YT; Yeh YS; Huang CW; Ma CJ; Wang JY
Pathol Oncol Res; 2019 Jul; 25(3):905-913. PubMed ID: 29299827
[TBL] [Abstract][Full Text] [Related]
19. Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer.
Mitsui Y; Shiina H; Yamamoto Y; Haramoto M; Arichi N; Yasumoto H; Kitagaki H; Igawa M
BJU Int; 2012 Dec; 110(11 Pt B):E628-34. PubMed ID: 22788759
[TBL] [Abstract][Full Text] [Related]
20. Cancer volume of lymph node metastasis predicts progression in prostate cancer.
Cheng L; Bergstralh EJ; Cheville JC; Slezak J; Corica FA; Zincke H; Blute ML; Bostwick DG
Am J Surg Pathol; 1998 Dec; 22(12):1491-500. PubMed ID: 9850175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
